Although ANKRD1 was initially reported to be upregulated in podocytes in various human kidney diseases, including crescentic glomerulonephritis, diabetic nephropathy, and lupus nephritis [43, 44], a recent report showed ANKRD1’s involvement in vascular injury [45]. Here, ANKRD1 is linked to crescentic glomerulonephritis.